Silexion Therapeutics Ltd. (SLXN) vs SciSparc Ltd. (SPRC)
A side-by-side comparison of Silexion Therapeutics Ltd. and SciSparc Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
SLXN
Silexion Therapeutics Ltd.
$0.26HealthcareDelayed quote: Oct 6, 2026, 2:14 PM EDT
SPRC
SciSparc Ltd.
$4.20HealthcareDelayed quote: Oct 6, 2026, 2:11 PM EDT
Total return — SLXN vs SPRC
growth of $100 · dividends reinvested · last 2ySLXN -100.0% (-99.0%/yr)SPRC -94.2% (-76.0%/yr)SPRC compounded faster over this window
Log scale — wide-divergence pair
SLXN SPRC
SLXN vs SPRC: by the numbers
- •SPRC is the larger company ($242924 vs $109358 market cap).
- •Both run net losses; SLXN's is the smaller (0.00% vs -1422.78% net margin).
Metrics side by side
Valuation
| Metric | SLXN | SPRC |
|---|---|---|
| P/B ratio | 2.49 | 0.06 |
Profitability
| Metric | SLXN | SPRC |
|---|---|---|
| Gross margin | 0.00% | 73.71% |
| Operating margin | 0.00% | -1022.08% |
| Net margin | 0.00% | -1422.78% |
| ROE | -31722.73% | -287.31% |
| ROIC | N/A | -152.82% |
Growth (annualized)
| Metric | SLXN | SPRC |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 9.25% |
| Total return CAGR (5Y) | N/A | -82.56% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.